Isolation, Transfection, and Long-Term Culture of Adult Mouse and Rat Cardiomyocytes
October 10th, 2020
9.1K views
Here, we present a protocol for the isolation, transfection, and long-term culture of adult mouse and rat cardiomyocytes.
Overview
This article presents a detailed, optimized protocol for the isolation, long-term culture, and siRNA transfection of adult mouse and rat cardiomyocytes (CMs). The method overcomes traditional limitations in culturing adult mouse CMs, enabling their survival and functional maintenance for over 20 days, which is critical for studies of cardiac biology, gene expression, and proliferation.
Key Study Components
Area of Science
- Cardiac cell biology
- Cell culture techniques
- Gene expression analysis
Background
- Adult mammalian cardiomyocytes are terminally differentiated with minimal proliferative capacity.
- Long-term culture of adult mouse CMs has been challenging due to poor survival beyond five days under standard conditions.
- Efficient isolation and culture are essential for studies on CM proliferation, gene expression, and cardiac disease modeling.
- Existing protocols for rat CMs are more successful, but mouse CMs require further optimization.
Purpose of Study
- To develop a standardized, reproducible protocol for isolating and culturing adult mouse and rat CMs for extended periods.
- To improve the efficiency of siRNA transfection in isolated CMs.
- To enable robust in vitro studies of CM biology, including proliferation and gene expression changes.
Methods Used
- Preparation and sterilization of surgical instruments and perfusion apparatus.
- Langendorff perfusion of excised mouse or rat hearts with optimized enzyme solutions for extracellular matrix dissociation.
- Removal of atria and non-cardiac tissues to obtain pure ventricular CMs.
- Enzymatic digestion, mechanical dissociation, and filtration to isolate single CMs.
- Pre-plating to remove contaminant cell types (e.g., fibroblasts).
- Plating of CMs on laminin-coated plates for rapid attachment.
- siRNA transfection using RNAiMAX reagent after 4–6 hours of plating.
- Long-term culture with daily media changes for up to 20 days.
- Immunofluorescent staining for cardiac (Troponin) and proliferation (Ki67) markers.
Main Results
- High survival rates (80–90%) of isolated adult mouse and rat CMs post-isolation.
- Efficient siRNA transfection, approaching 100% in cultured CMs.
- Maintenance of healthy, contractile, and morphologically intact CMs for over 20 days in culture.
- Successful induction and detection of CM proliferation using Ki67 staining after siRNA transfection.
Conclusions
- The optimized protocol enables reliable long-term culture and genetic manipulation of adult mouse and rat CMs.
- This method facilitates advanced studies of CM biology, including proliferation and gene expression, previously limited by poor cell survival.
- Mastery of this technique expands experimental possibilities for cardiac research using adult mammalian CMs.
Frequently Asked Questions
What is the main advantage of this protocol over previous methods for culturing adult mouse cardiomyocytes?
This protocol allows adult mouse cardiomyocytes to survive and remain functional for over 20 days in culture, compared to less than one week with standard methods.
How are contaminating cell types removed during the isolation process?
A pre-plating step is used, where non-cardiomyocyte cells such as fibroblasts adhere to the dish, allowing for the collection of pure, floating cardiomyocytes.
What transfection reagent is used for siRNA delivery in this protocol?
RNAiMAX transfection reagent is used to achieve high-efficiency siRNA transfection in isolated cardiomyocytes.
How is the health and proliferation of cultured cardiomyocytes assessed?
Cardiac-specific markers (e.g., Troponin) and proliferation markers (e.g., Ki67) are detected by immunofluorescent staining, and cell morphology and contractility are monitored by microscopy.
What are the critical steps for successful long-term culture of adult CMs?
Key steps include optimized enzymatic digestion, careful removal of non-cardiac tissues, use of laminin-coated plates for attachment, and daily media changes with appropriate supplements.
Can this protocol be applied to both mouse and rat cardiomyocytes?
Yes, the protocol is optimized for both adult mouse and rat cardiomyocytes, enabling long-term culture and genetic manipulation in both species.
What applications does this protocol enable in cardiac research?
It enables studies of cardiomyocyte proliferation, gene expression, response to injury, and other aspects of cardiac cell biology in a controlled in vitro environment.
Executive Industry Relevance
Reliable long-term culture and transfection of adult mouse and rat cardiomyocytes addresses a critical bottleneck in cardiac target validation and mechanistic de-risking. This protocol enables extended in vitro studies of gene function, proliferation, and cellular response, supporting predictive confidence at early discovery and preclinical inflection points. The method's reproducibility and scalability enhance portfolio decision-making for cardiac drug discovery programs.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables direct interrogation of cardiac gene function and pathway analysis in adult cardiomyocytes.
- Supports mechanistic de-risking by allowing controlled manipulation and observation of post-mitotic cardiac cells.
- Facilitates robust target validation through extended viability and functional maintenance of primary cells.
Screening & Assay Development
- Provides a standardized, reproducible system for quantitative assessment of gene expression and proliferation markers.
- Improves assay readiness by supporting high-efficiency siRNA transfection and consistent cell health over 20 days.
- Enables reliable evaluation of compound effects in a physiologically relevant cardiac cell context.
Translational & Preclinical Research
- Aligns in vitro findings with disease-relevant cardiac biology for translational biomarker exploration.
- Supports continuity from discovery through preclinical validation by maintaining adult cardiomyocyte phenotype and function.
- Reduces translational risk by enabling long-term studies of cardiac response to genetic or pharmacological perturbation.
Pipeline & Workflow Integration
This protocol integrates into the discovery-to-preclinical continuum, bridging early hypothesis testing with downstream functional validation in cardiac research.
- Discovery Biology: Supports hypothesis-driven studies of gene function and cellular response in adult cardiomyocytes.
- Screening: Delivers reproducible, quantitative outputs for gene expression and proliferation assays.
- Analytics: Enables statistical comparison of transfection efficiency, survival rates, and marker expression across conditions.
- Translational Research: Maintains disease-relevant cell states for biomarker and mechanistic studies.
- Enterprise Reuse: Establishes a reusable platform for cardiac cell-based assays and genetic manipulation workflows.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces ambiguity in cardiac target validation.
- Operational Value: Standardizes isolation, culture, and transfection for reproducible, scalable workflows.
- Strategic Value: Enables informed go/no-go decisions and capital-efficient advancement of cardiac programs.
- Portfolio Impact: Supports risk-adjusted prioritization by providing robust, long-term cardiac cell data.
Implementation Considerations
- Requires expertise in cardiac cell isolation, perfusion, and sterile technique.
- Needs access to Langendorff perfusion apparatus, cell culture infrastructure, and imaging systems.
- Demands cross-team standardization of enzymatic digestion, plating, and transfection protocols.
- Adaptation may be needed for different rodent strains or cardiac disease models.
- Long-term culture success depends on precise media composition and daily maintenance.
Biopharma FAQs
Why is null hypothesis testing important for siRNA transfection in cardiomyocytes?
Null hypothesis testing ensures that observed changes in gene expression or proliferation after siRNA transfection are statistically significant and not due to baseline variability in cultured cardiomyocytes, supporting robust target validation decisions.
How does independent variable isolation during Langendorff perfusion support discovery?
Isolating the heart and controlling enzymatic digestion parameters during Langendorff perfusion allows precise manipulation of experimental variables, enabling clear attribution of cellular responses to specific interventions in early discovery workflows.
What do quantitative Ki67 and Troponin measurements enable in this protocol?
Quantitative assessment of Ki67 and Troponin expression provides objective readouts of cardiomyocyte proliferation and identity, enabling comparative analysis across experimental conditions and supporting data-driven advancement decisions.
Why are replication requirements critical for cross-functional cardiac research teams?
Replication of isolation, culture, and transfection steps ensures reproducibility and reliability of results, facilitating collaboration and data integration across discovery, screening, and translational research teams.
What statistical analysis capabilities are needed before implementing long-term culture assays?
Teams must be equipped to perform survival rate calculations, transfection efficiency quantification, and marker expression analysis to validate assay performance and interpret experimental outcomes with confidence.
